Dr. Michael is Managing Director of IPQ Analytics, LLC, and Strategic Medicine, Inc., with expertise in theoretical chemistry, protein crystallography, and computational biology. A prolific academic and industry leader, he has held roles at Drexel College of Medicine, University of Massachusetts-Lowell, and Roche Pharma. He advises on digital health and quantum computing, focusing on computational models for disease progression, drug development, and clinical pathways. His work spans oncology, cardiology, and maternal health, emphasizing risk detection and stratification through systems-based design thinking.